Funds
BVP Fund IV
BVP Fund IV was established in April 2021. Limited partners of the fund are DSM Nederland, NV LIOF, Limburg Province and Rabobank. The fund size at first closing is € 45 million. The Rijksdienst voor Ondernemend Nederland (RVO) has committed € 10 mln out of the Seedcapitalregeling. The fund’s life is 12 years with an investment period of 6 years during which it aims to invest in up to 15-20 companies.
BVP FundIV invests in innovative companies with a link to the Brightlands ecosystem. The Brightlands ecosystem has its root in four centers of gravity:
- Chemistry and circularity R&D and production around the Brightlands Chemelot Campus in Geleen
- Academic biomedical R&D at the Brightlands Maastricht Health Campus
- Agrifood technologies and nutrition R&D at the Brightlands Campus Greenport Venlo
- Data Science and smart services at the Brightlands Smart Services Campus in Heerlen
The Brightlands ecosystem has developed around these four campuses, with ties to strongholds in Eindhoven, Aachen and Leuven, Brightlands was built on the strengths of world leading innovative industrial companies such as BASF, Fresenius, Lonza and Saudi Aramco and a myriad of young innovative companies and R&D institutes.
For more information about Brightlands visit: http://www.brightlands.com
Facts & Figures | |
|---|---|
| Legal name | Brightlands Venture Partners Fund IV |
| Start | 2021 |
| Domicile | The Netherlands |
| Limited partners | DSM Nederland BV, NV LIOF, Province of Limburg, Coöperatieve Rabobank U.A. |
| Type | Closed-end fund |
| Size | € 45 million at first closing |
| Investment focus by sector | Renewable chemistry & circularity, regenerative medicine & biomedical materials, agritech & food and supportive digital technologies |
| Investment focus by stage | Early stage as well as later stage |
| Ecosystem | Fit with the Brigthlands Ecosystem |
Selected portfolio companies
ReSolved Technologies
Advanced solvent-based recycling of engineering plastics and soft pvcAliform
Medical devices for minimally-invasive skin surgeryCircularise
End-to-end supply chain traceabilityBrightlands Agrifood Fund
Brightlands Agrifood Fund was established in 2017 to include agrifood technology startups in our focus. This was triggered by the fast growth of the Brightlands Campus Greenport Venlo. Limited partners of the fund are Rabobank, Province of Limburg, NV LIOF, LLTB (Limburgse Land- en Tuinbouwbond), Van Herk Ventures and an undisclosed private individual active in modern greenhouse farming. The Rijksdienst voor Ondernemend Nederland (RVO) has committed € 6 million out of the so-called Seedcapitalregeling. More facts can be viewed below:
Facts & Figures | |
|---|---|
| Legal name | Brightlands Agrifood Fund BV |
| Start | 2017 |
| Domicile | The Netherlands |
| Limited partners | Coöperatieve Rabobank U.A., Province of Limburg, NV LIOF, LLTB (Limburgse Land- en Tuinbouwbond), Van Herk Ventures, a private individual active in modern greenhouse farming, and fund management |
| Type | Closed-end fund |
| Size | € 20.1 million |
| Investment focus by sector | Agriculture (seed & grow) and food (harvest & formulate) |
| Investment focus by stage | Early stage, including the ‘seed’ phase |
Selected portfolio companies
Greencovery
Upcycling valuable ingredients from food production side-streamsS&dB
Plant seed-embedding technologyPectcof
Functional food ingredients from coffeeChemelot Ventures
Chemelot Ventures was established as a successor to Limburg Ventures in 2014. Limited partners of the fund are DSM Nederland, NV LIOF, Limburg Province and Rabobank, each with a commitment of € 10 million. The fund’s life is 12 years with an investment period of six years during which it has invested in 19 companies.
Facts & Figures | |
|---|---|
| Legal name | Chemelot Ventures BV |
| Start | 2014 |
| Domicile | The Netherlands |
| Limited partners | DSM Nederland BV, NV LIOF, Province of Limburg, Coöperatieve Rabobank U.A. |
| Type | Closed-end fund |
| Size | € 40 million |
| Investment focus by sector | Sustainable chemicals & materials, regenerative medicine & biomedical materials and diagnostics & analytics |
| Investment focus by stage | Early stage as well as later stage |
Selected portfolio companies
Fuenix
Chemical recycling of mixed plastic wasteNeuroplast
Autologous stem cell therapies for neurodegenerative diseasesVacis
Synthetic rod technology forming fully functional blood vesselsLimburg Ventures
Limburg Ventures is the predecessor fund of Chemelot Ventures. It was set up in 2004 and made 22 investments. The active investment period is over and is in its exit phase. It has realized several successful exits and still has a number of participations in its portfolio. Below you will find an overview of the most relevant facts regarding Limburg Ventures:
Facts & Figures | |
|---|---|
| Legal name | Limburg Ventures BV |
| Start | 2004 |
| Domicile | The Netherlands |
| Limited partners | DSM Nederland BV, NV LIOF |
| Type | Closed-end fund |
| Size | € 15 million |
| Investment focus by sector | Life sciences (regenerative medicine, drug delivery, drug screening, and formulation and diagnostics), advance materials ((bio-based) polymers and coatings, processing and applications) |
| Investment focus by stage | Early stage (in principle, past the ‘seed’ phase) |
Selected portfolio companies
Pharmalot
National, generic pharmacy preparations to dispensing pharmacistsKriya Materials
High performance coatingsFortimedix Surgical
Endoscopic instruments and related equipmentMore information
If you have any questions or want to know more about us
Contact us